RFG Advisory LLC acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 2,055 shares of the biotechnology company’s stock, valued at approximately $323,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Tradewinds Capital Management LLC purchased a new stake in Axon Enterprise during the 3rd quarter valued at about $26,000. Assetmark Inc. acquired a new position in Axon Enterprise in the 3rd quarter valued at about $35,000. Adirondack Trust Co. acquired a new position in Axon Enterprise in the 3rd quarter valued at about $45,000. Signaturefd LLC acquired a new position in Axon Enterprise in the 3rd quarter valued at about $49,000. Finally, Trust Co. of Vermont acquired a new position in Axon Enterprise in the 4th quarter valued at about $47,000. 75.47% of the stock is owned by institutional investors.
Shares of AXON stock opened at $127.82 on Monday. The firm has a market cap of $9.07 billion, a P/E ratio of -129.11, a P/E/G ratio of 10.29 and a beta of 0.42. Axon Enterprise, Inc. has a one year low of $117.05 and a one year high of $209.00. The firm’s 50 day moving average price is $135.42 and its 200-day moving average price is $152.71.
In related news, CFO Jawad A. Ahsan sold 4,840 shares of the stock in a transaction on Tuesday, April 5th. The shares were sold at an average price of $141.17, for a total value of $683,262.80. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.30% of the company’s stock.
Several equities analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a report on Friday, March 4th. JMP Securities assumed coverage on shares of Axon Enterprise in a report on Tuesday, December 14th. They issued an “outperform” rating and a $195.00 target price on the stock. JPMorgan Chase & Co. upgraded shares of Axon Enterprise from a “neutral” rating to an “overweight” rating and decreased their target price for the company from $222.00 to $192.00 in a report on Friday, February 25th. Northland Securities decreased their target price on shares of Axon Enterprise from $220.00 to $180.00 in a report on Monday, February 28th. Finally, Robert W. Baird reiterated a “buy” rating and issued a $175.00 target price on shares of Axon Enterprise in a report on Friday, February 25th. One equities research analyst has rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $193.38.
About Axon Enterprise (Get Rating)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
- Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
- PayPal Stock is Still Ready for Bargain Hunting
- It’s Personal: 3 Personal Care Stocks to Own in Volatile Markets
- Conagra Stock Has More Room to Grow
- 3 Recession-Proof Stocks to Buy Now
- MarketBeat: Week in Review 4/4 – 4/8
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.